4.0
Jul 12, 2015
Recommend
CEO approval
Business Outlook
Pros
- Upward mobility - Nice pipeline - deep benefits - focus on culture and development
Cons
- Owned by Novartis - true Caps on earnings in Sales Role - poor analytics and partnership with inefficient sales vendors